- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02155855
Telemedicine for Adolescents With Insulin-dependent Diabetes
Effectiveness of and Satisfaction With Remote Blood Glucose Monitoring and Telemedicine for Adolescents With Insulin-dependent Diabetes
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Group Study group will be asked to test blood glucose at least 4 times a day Each time the study subject takes a meter reading the meter time-stamps the reading. All meter readings will upload to the cloud via" Myglucohealth" website, where they can be accessed by caregivers, including providers and parents. Device will be programmed to coax patients when readings are due. Parents will be notified by device about the blood glucose testing results. Provider will set device to alert patient or patient's family if patient has not yet tested or uploaded a test or send alerts to parent if uploaded numbers are outside an identified range (<70 mg/dL > 300 mg/dL). As per the standard of care, parents are trained to administer sugar containing liquids, or inject extra insulin for hyperglycemia correction. Parents will be encouraged to contact study personnel if they are concerned about the diabetes control. Study personnel will access home blood glucose monitor data, and provide insulin dosing advice. Parents will be asked to upload blood glucose readings prior to each visit.
Control group Subjects will continue routine care which requires blood glucose testing at least 4 times a day. Parents will use customary ways to communicate (pager, email, fax or phone) with the Diabetes team, if they are concerned about glycemic control..
Study group will have two virtual visits (months 3 and 6) Control group will have all quarterly visits in person. A laptop will be used for virtual visits and will be set up with the help of the TTUHSC Information Technology Security Officer.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Lubbock, Texas, United States, 79410
- TTUHSC Pediatric Clinic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
-- Age 10-18 years
- Multiple daily injections regimen
- Duration of diabetes > 12 months
- HbA1c > 7%
- Lives outside of Lubbock
- Committed to visit schedule
Exclusion Criteria:
- Foster care or residential facility
- Psychiatric illness
- Developmental delay
- Reading at < 4th grade level
- Pregnancy
- Known seizure disorder
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Telemedicine
Telemedicine group will test blood glucose at least 4 times a day Each time the meter time-stamps the reading.
All meter readings will upload to the cloud via "Myglucohealth" website, where they can be accessed by caregivers, including providers and parents.
Parents will be notified by device about the blood glucose testing results.
Provider will set device to alert patient or patient's family or send alerts if uploaded numbers are outside an identified range (<70 mg/dL > 300 mg/dL).
As per the standard of care, parents are trained to administer sugar containing liquids, or inject extra insulin for hyperglycemia correction.
Parents will be encouraged to contact study personnel if they are concerned about the diabetes control.
Study personnel will access home blood glucose monitor data, and provide insulin dosing advice.
Parents will be asked to upload blood glucose readings prior to each visit.
|
Study group will test blood glucose at least 4 times a day Each time the meter timestamps the reading.
All meter readings will upload to the cloud via Myglucohealth website, where they can be accessed by caregivers, including providers and parents.
Parents will be notified by device about the blood glucose testing results.
Provider will set device to alert patient or patient's family or send alerts if uploaded numbers are outside an identified range (<70 mg/dL > 300 mg/dL).
As per the standard of care, parents are trained to administer sugar containing liquids, or inject extra insulin for hyperglycemia correction.
Parents will be encouraged to contact study personnel if they are concerned about the diabetes control.
Study personnel will access home blood glucose monitor data, and provide insulin dosing advice.
Parents will be asked to upload blood glucose readings prior to each visit.
|
Active Comparator: Control
Control Subjects will continue routine care which requires blood glucose testing at least 4 times a day.
Parents will use customary ways to communicate (pager, email, fax or phone) with the Diabetes team, if they are concerned about glycemic control..
|
Routine care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
hemoglobin A1c
Time Frame: 12 months
|
As an indicator of diabetes control
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Frequency of contact with diabetes care team
Time Frame: 12 months
|
To see if tele-communication is used more than the conventional (phone, FAX)
|
12 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Daina Dreimane, MD, TTUHSC School of Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- L14-037
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 1 Diabetes
-
Poznan University of Medical SciencesUnknownDiabetes Mellitus Type 1 | Remission of Type 1 Diabetes | Chronic Complications of DiabetesPoland
-
Eledon PharmaceuticalsWithdrawnBrittle Type 1 Diabetes MellitusUnited States
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)CompletedType 1 Diabetes Mellitus | T1DM | T1D | New-onset Type 1 Diabetes MellitusUnited States, Australia
-
Hoffmann-La RocheCompletedType 2 Diabetes, Type 1 DiabetesAustria, United Kingdom
-
Shanghai Changzheng HospitalRecruitingBrittle Type 1 Diabetes MellitusChina
-
Capillary Biomedical, Inc.TerminatedType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMAustria
-
Capillary Biomedical, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Insulin-Dependent, 1Australia
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
Rabin Medical CenterDreaMed DiabetesTerminated
Clinical Trials on Telemedicine
-
NHS Greater Glasgow and ClydeUniversity of Strathclyde; Microsoft CorporationNot yet recruiting
-
University of RochesterAgency for Healthcare Research and Quality (AHRQ)CompletedTelemedicine | Physical DisordersUnited States
-
NHS Greater Glasgow and ClydeJean Brown Bequest Fund, Glasgow, UKNot yet recruitingTelemedicine | Surgery, PlasticUnited Kingdom
-
NHS Greater Glasgow and ClydeUniversity of Strathclyde; Microsoft CorporationCompletedTelemedicine | Reconstructive Surgery | 3 DimensionalUnited Kingdom
-
NHS Greater Glasgow and ClydeUniversity of Strathclyde; Glasgow Royal InfirmaryNot yet recruiting
-
University of MichiganCompleted
-
SciensanoEuropean CommissionRecruitingCancerHungary, Greece, Belgium, Cyprus, Ireland, Italy, Lithuania, Portugal, Slovenia, Spain
-
University of Cape TownKarolinska Institutet; University of California, San Francisco; Grand Challenges...Recruiting
-
University Hospital MuensterPalliativnetz Muenster gGmbH; CompuGroup MedicalCompletedCancer | Chronic Obstructive Pulmonary Disease | Chronic Heart Failure | Palliative CareGermany
-
Aalborg UniversityCompleted